# Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)

> **NCT05282498** · — · UNKNOWN · sponsor: **National Heart Centre Singapore** · enrollment: 50 (estimated)

## Conditions studied

- Myocarditis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05282498
- **Lead sponsor:** National Heart Centre Singapore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-04-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05282498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05282498, "Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05282498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*